Scotland Stevens

General Partner at OrbiMed

About

General Partner Scotland Stevens has a broad cross-firm trading mandate across units, regions and products, pairing Goldman Sachs equity-derivatives and healthcare trading expertise with Seed/Series A digital health investments ($1M–$75M).

LinkedIn ↗

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Colleagues at OrbiMed

Alexandria Huynh

Analyst at OrbiMed

Anat Nursella

Venture Partner at OrbiMed

Brendan Weber

Principal at OrbiMed

C. Scotland Stevens

General Partner at OrbiMed

Carl Gordon

Managing Partner at OrbiMed

Carter Neild

Managing Partner at OrbiMed